Neutrophil Gelatinase-Associated Lipocalin and Kidney Diseases

키워드

참고문헌 (69)

1. Singer E, "Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications", Acta Physiol (Oxf), 207, pp.663~672 (2013)
2. Kjeldsen L, "Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase", J Biol Chem, 268, pp.10425~10432 (1993)
3. Lisowska-Myjak B, "Serum and urinary biomarkers of acute kidney injury", Blood Purif, 29, pp.357~365 (2010)
4. Schmidt-Ott KM, "Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia", Curr Opin Nephrol Hypertens, 15, pp.442~449 (2006)
5. Singer E, "Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes", Kidney Int, 80, pp.405~414 (2011)
6. Zheng J, "Comparison of urinary biomarkers for early detection of acute kidney injury after cardiopulmonary bypass surgery in infants and young children", Pediatr Cardiol, 34, pp.880~886 (2013)
7. Bolignano D, "Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease", Clin J Am Soc Nephrol, 4, pp.337~344 (2009)
8. Hollmen ME, "Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation", Kidney Int, 79, pp.89~98 (2011)
9. Ichino M, "Urinary neutrophil-gelatinase associated lipocalin is a potential noninvasive marker for renal scarring in patients with vesicoureteral reflux", J Urol, 183, pp.2001~2007 (2010)
10. Ding H, "Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy", Clin Immunol, 123, pp.227~234 (2007)
11. Bolignano D, "Pathological and prognostic value of urinary neutrophil gelatinaseassociated lipocalin (NGAL) in macroproteinuric patients with worsening renal function", Kidney Blood Press Res, 31, pp.274~279 (2008)
12. Peters HP, "High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy", Nephrol Dial Transplant, 26, pp.3581~3588 (2011)
13. Wu Y, "Urinary neutrophil gelatinaseassociated lipocalin: A potential biomarker for predicting rapid progression of drug-induced chronic tubulointerstitial nephritis", Am J Med Sci, 339, pp.537~542 (2010)
14. Piccoli GB, "The search for perfect biomarkers in acute kidney damage: the case of NGAL, from AKI to acute pyelonephritis: back to the clinic?", Nephrol Dial Transplant, 27, pp.3665~3666 (2012)
15. Yilmaz A, "Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin", Pediatr Nephrol, 24, pp.2387~2392 (2009)
16. Seo WH, "A rapid plasma neutrophil gelatinase-associated lipocalin assay for diagnosis of acute pyelonephritis in infants with acute febrile urinary tract infections: a preliminary study", Eur J Pediatr, 173, pp.229~232 (2014)
17. Yim HE, "Predictive value of urinary and serum biomarkers in young children with febrile urinary tract infections", Pediatr Nephrol, 29, pp.2181~2189 (2014)
18. Sim JH, "Plasma neutrophil gelatinase-associated lipocalin predicts acute pyelonephritis in children with urinary tract infections", Pediatr Res, 78, pp.48~55 (2015)
19. Borregaard N, "Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein", Biometals, 19, pp.211~215 (2006)
20. Devireddy LR, "A cell surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake", Cell, 123, pp.1293~1305 (2005)
21. Goetz DH, "The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition", Mol Cell, 10, pp.1033~1043 (2002)
22. Berger T, "Lipocalin 2-deficientmice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury", Proc Natl Acad Sci USA, 103, pp.1834~1839 (2006)
23. Flo TH, "Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron", Nature, 432, pp.917~921 (2004)
24. Schmidt-Ott KM, "Dual action of neutrophil gelatinase-associated lipocalin", J Am Soc Nephrol, 18, pp.407~413 (2007)
25. Yang J, "An epithelial precursor is regulated by the ureteric bud and by the renal stroma", Dev Biol, 246, pp.296~310 (2002)
26. Cowland JB, "Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase associated lipocalin from humans", Genomics, 45, pp.17~23 (1997)
27. Mishra J, "Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury", J Am Soc Nephrol, 14, pp.2534~2543 (2003)
28. Mehta RL, "Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury", Crit Care, 11, pp.R31~ (2007)
29. Clerico A, "Neutrophil gelatinaseassociated lipocalin (NGAL) as biomarker of acute kidney injury:a review of the laboratory characteristics and clinical evidences", Clin Chem Lab Med, 50, pp.1505~1517 (2012)
30. Wagener G, "Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery", Am J Kidney Dis, 52, pp.425~433 (2008)
31. Hirsch R, "NGAL is an early predictive biomarker of contrast-induced nephropathy in children", Pediatr Nephrol, 22, pp.2089~2095 (2007)
32. Lattanzio MR, "Acute kidney injury: new concepts in definition, diagnosis, pathophysiology, and treatment", J Am Osteopath Assoc, 109, pp.13~19 (2009)
33. Supavekin S, "Differential gene expression following early renal ischemia-reperfusion", Kidney Int, 63, pp.1714~1724 (2003)
34. Devarajan P, "Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics", Mol Genet Metab, 80, pp.365~376 (2003)
35. Han M, "Renal neutrophil gelatinase associated lipocalin expression in lipopolysaccharide-induced acute kidney injury in the rat", BMC Nephrol, 13, pp.25~ (2012)
36. Hoffmann D, "Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity", Toxicology, 277, pp.49~58 (2010)
37. Mori K, "Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury", J Clin Invest, 115, pp.610~621 (2005)
38. Dent CL, "Plasma NGAL predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study", Crit Care, 11, pp.R127~ (2007)
39. Bennett M, "Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study", Clin J Am Soc Nephrol, 3, pp.665~673 (2008)
40. Koyner JL, "Biomarkers predict progression of acute kidney injury after cardiac surgery", J Am Soc Nephrol, 23, pp.905~914 (2012)
41. Bachorzewska-Gajewska H, "Neutrophilgelatinase-associated lipocalin and renal function after percutaneous coronary interventions", Am J Nephrol, 26, pp.287~292 (2006)
42. Haase M, "Accuracy of neutrophil gelatinase-associated lipocalin(NGAL)in diagnosis and prognosis in acute kidney injury : a systematic review and meta-analysis", Am J Kidney Dis, 54, pp.1012~1024 (2009)
43. Bagshaw SM, "Plasma and urine neutrophil gelatinaseassociated lipocalin in septic versus non-septic acute kidney injury in critical illness", Intensive Care Med, 36, pp.452~461 (2010)
44. Ronco C, "Cardio-renal syndromes : report from the consensus conference of the acute dialysis quality initiative", Eur Heart J, 31, pp.703~711 (2010)
45. Damman K, "Urinary neutrophil gelatinase associated lipocalin (NGAL),a marker of tubular damage, is increased in patients with chronic heart failure", Eur J Heart Fail, 10, pp.997~1000 (2008)
46. Haase M, "The outcome of neutrophil gelatinaseassociated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies", J Am Coll Cardiol, 57, pp.1752~1761 (2011)
47. Viau A, "Lipocalin 2 is essential for chronic kidney disease progression in mice and humans", J Clin Invest, 120, pp.4065~4076 (2010)
48. Kusaka M, "Serumneutrophil gelatinase-associated lipocalin as a predictor of organ recovery from delayed graft function after kidney transplantation applying donation after cardiac death", Cell Transplant, 17, pp.129~134 (2008)
49. Wasilewska A, "KIM-1 and NGAL: new markers of obstructive nephropathy", Pediatr Nephrol, 26, pp.579~586 (2011)
50. Eddy AA, "Chronic kidney disease progression", J Am Soc Nephrol, 17, pp.2964~2966 (2006)
51. Levey AS, "National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification", Ann Intern Med, 139, pp.137~147 (2003)
52. Clark WF, "Dipstick proteinuria as a screening strategy to identify rapid renal decline", J Am Soc Nephrol, 22, pp.1729~1736 (2011)
53. Fassett RG, "Biomarkers in chronic kidney disease: a review", Kidney Int, 80, pp.806~821 (2011)
54. Smith ER, "Urinary neutrophil gelatinase-associated lipocalin may aidprediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD)", Nephrol Dial Transplant, 28, pp.1569~1579 (2013)
55. Nickolas TL, "NGAL(Lcn2)monomer is associated with tubulointerstitial damage in chronic kidney disease", Kidney Int, 82, pp.718~722 (2012)
56. Mitsnefes MM, "Serum neutrophil gelatinaseassociatedlipocalin as a marker of renal function in children with chronickidney disease", Pediatr Nephrol, 22, pp.101~108 (2007)
57. Bhavsar NA, "Neutrophil gelatinaseassociatedlipocalin(NGAL)and kidney injury molecule 1(KIM-1)as predictors of incident CKD stage 3 : the Atherosclerosis Risk in Communities(ARIC)Study", Am J Kidney Dis, 60, pp.233~240 (2012)
58. Liu KD, "Urine neutrophil gelatinase–associated lipocalin levels do not improve risk prediction of progressivechronic kidney disease", Kidney Int, 83, pp.909~914 (2013)
59. Braun V, "Active transport of iron and siderophore antibiotics", Curr Opin Microbiol, 5, pp.194~201 (2002)
60. Johnson JR, "High-frequency secondary mutations after suicide-driven allelic exchange mutagenesis in extraintestinal pathogenic Escherichia coli", J Bacteriol, 185, pp.5301~5305 (2003)
61. Wu H, "Lipocalin 2 is protective against E. coli pneumonia", Respir Res, 11, pp.96~ (2010)
62. Ichino M, "Increased urinary neutrophil gelatinase associated lipocalin levels in a rat model of upper urinary tract infection", J Urol, 181, pp.2326~2331 (2009)
63. Wheeler DS, "Serum neutrophil gelatinase-associated lipocalin(NGAL)as amarker of acute kidney injury in critically ill children with septic shock", Crit Care Med, 36, pp.1297~1303 (2008)
64. Xu S, "Serum measurements of humanneutrophil lipocalin(HNL)discriminate between acute bacterial and viral infections", Scand J Clin Lab Invest, 55, pp.125~131 (1995)
65. Fjaertoft G, "Human neutrophil lipocalin(HNL)as a diagnostic tool in children with acute infections : a study of the kinetics", Acta Paediatr, 94, pp.661~666 (2005)
66. Björkqvist M, "Human neutrophil lipocalin : normal levels and use as a marker for invasive infection in the newborn", Acta Paediatr, 93, pp.534~539 (2004)
67. Montini G, "Febrile urinary tract infections in children", N Engl J Med, 365, pp.239~250 (2011)
68. Roberts KB, "Urinary tract infection : clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months", Pediatrics, 128, pp.595~610 (2011)
69. Rushton HG, "The evaluation of acute pyelonephritis and renal scarring with technetium 99m-dimercaptosuccinic acid renal scintigraphy: evolving concepts and future directions", Pediatr Nephrol, 11, pp.108~120 (1997)

관련 논문AI추천